Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
about
Mass spectrometry for the assessment of the occurrence and biological consequences of DNA adductsQuantitation of DNA adducts by stable isotope dilution mass spectrometry.Nuclease digestion and mass spectrometric characterization of oligodeoxyribonucleotides containing 1,2-GpG, 1,2-ApG, and 1,3-GpXpG cisplatin intrastrand cross-links.Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.Speciation of oxaliplatin adducts with DNA nucleotides.The physical and chemical stability of cisplatin (Teva) in concentrate and diluted in sodium chloride 0.9%.Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).Liquid chromatography-mass spectrometry as a general approach for investigating covalent binding of drugs to DNA.On the complexity and dynamics of in vivo Cisplatin-DNA adduct formation using HPLC/ICP-MS.
P2860
Q28082391-F0642E0F-D967-40C5-84E7-9CB3BD393932Q36390390-6EA4A379-6DE8-4C14-BFA5-18E10BD63E2BQ36763096-0574874C-2B5C-44EC-9DCE-D69234CAA2ACQ36817080-CC0D801D-ABD8-4952-AD8C-4E9F192A594AQ37182939-42DB32C6-898C-49E3-8DCB-03C4280DA6F6Q39486608-E8303F64-9B77-4F4A-BABB-2830E0272814Q42198967-5BB50D6D-48DE-4274-9FC6-143E15A9621EQ46719997-5141783E-65E4-40B3-9ED5-9F91E27F1BDEQ50867137-07293A6B-6A1D-498E-9354-76B77AE30A19Q52886835-FE6FAAC5-AAF0-4160-A36F-AA9DD90EB899
P2860
Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of an ultraperform ...... trand guanine-guanine adducts.
@en
Development of an ultraperform ...... trand guanine-guanine adducts.
@nl
type
label
Development of an ultraperform ...... trand guanine-guanine adducts.
@en
Development of an ultraperform ...... trand guanine-guanine adducts.
@nl
prefLabel
Development of an ultraperform ...... trand guanine-guanine adducts.
@en
Development of an ultraperform ...... trand guanine-guanine adducts.
@nl
P2093
P2860
P356
P1476
Development of an ultraperform ...... trand guanine-guanine adducts.
@en
P2093
Candice King
Esra Mutlu
Gunnar Boysen
Irene M Baskerville-Abraham
J Mitchell Troutman
James A Swenberg
Kathryn E Dekrafft
Leonard Collins
Stephen G Chaney
Wenbin Lin
P2860
P304
P356
10.1021/TX800481J
P577
2009-05-01T00:00:00Z